Definitive Healthcare Corp. (DH)

From the record

Definitive Healthcare Corp.'s filings since 2021 show 3 warning events of 3 kinds: a notice about its exchange listing (8-K item 3.01, the latest 2026-06-24); a warning not to rely on past financial statements (8-K item 4.02, the latest 2023-08-01); a late-report notice (Form NT 10-K or NT 10-Q, the latest 2023-08-01) (its current reports).

From the record

Definitive Healthcare Corp.'s 6 filed years say what it did: revenue went from $118 million in fiscal 2020 to $242 million in fiscal 2025, up 15.3% a year; it rose in 4 of 5 years; the deepest fall was 4% from fiscal 2024 to fiscal 2025; net income was positive in 0 of 6 of those years (its annual reports).

From the record

Over the 3 fiscal years to 2025-12-31, Definitive Healthcare Corp.'s diluted share count grew about 1.8% a year, and dividends and buybacks returned about 47% of its operating cash flow over 3 years (its filed statements). Its officers and directors filed 0 sales and 0 purchases of their own stock on the open market in the year to 2026-11-03 (their Form 4 filings).

From the record

Return on equity: in the fiscal year ended 2025-12-31, Definitive Healthcare Corp. lost about 37 cents for every dollar of shareholders' money, and gross profitability: its products earned about 25 cents per dollar of everything the company owns. Leverage: it owed about 48 cents per dollar of assets, and net share issuance: its share count shrank 8.6% over the year (the filed statements).

From the record

Definitive Healthcare Corp.'s standing among 218 graded names in its industry family: revenue of $242 million in fiscal 2025 ranks in the bottom 39% by size; a net margin of -57.5% ranks in the bottom 19%; revenue growth of 2.7% a year over the last 3 filed years ranks in the bottom 26% (its annual reports).

From the record

Definitive Healthcare Corp.'s leadership, from its insiders' filings and its current reports: the chief executive on the record is Ritchey, Clay Brian (Chief Executive Officer, as filed), filing under that title since 2026-09-16, 2 months (bottom 4% of its family); the 10 officers and directors filing in the last fifteen months have been on the record a median of 2.8 years (bottom 8%); 12 officer or director changes were reported on Form 8-K since 2023-11-13, against the 10 people in charge now (bottom 7%; fewer changes for each person reads higher) (the Form 4 record, its Form 8-K reports). Years count from a person's first filing in the SEC's data sets, which begin in 2006, so each is a floor.

From the record

Definitive Healthcare Corp.'s room to grow, from the newest filed statements (fiscal 2025): cash of $164 million against debt of $156 million leaves 1% of its assets as net cash, bottom 25% of its family; cash from operations less capital spending is 15.3% of revenue (top 47%); a gross margin of 75.9% (top 34%); research spending of 14.4% of revenue (bottom 28%) (its annual report).

From the record

Definitive Healthcare Corp.'s growth drivers, from the filed years to fiscal 2025: revenue grew 2.7% a year over the last three filed years against 15.3% over all 6, slowing (bottom 31% of its family); the newest year grew -4.2% (bottom 13%); research spending grew -0.1% a year (bottom 30%); capital spending grew 26.2% a year (top 23%) (its annual reports). Definitive Healthcare Corp. reported 2 product lines in fiscal 2025: Subscription Services at $232 million (96%), Professional Services at $9 million (4%); 1 of 2 grew against the year before (its annual report).

From the record

Definitive Healthcare Corp.'s newest year against its own record: revenue of $242 million in fiscal 2025 came in 10% below the $268 million its prior three years' pace pointed to (bottom 16% of its family); net income of $139 million against a prior three-year average of $208 million (bottom 47%); a net margin of -57.5% against -82.5% before (top 24%) (its annual reports).